Luc Boblet is a biotech serial entrepreneur with 15 years of experience in technology transfer, business development and corporate finance. Before co-founding H-IMMUNE, Luc co-founded and ran Pathoquest, a start-up company spun out of Institute Pasteur, which develops disruptive unbiased NGS-based diagnostics in the field of infectious diseases. Under his guidance, Pathoquest raised two VC-backed rounds of financing, closed multiple strategic collaborations and corporate partnerships with leading pharma companies (CERBA Laboratories and Covance), and launched several clinicals trials in France and the U.S. From 2011 to 2015, he served on the board of directors of the BioAster Technological Research Institute. Dr. Boblet holds a biotech engineering degree and a PhD in Virology from University Paris VII.
technology transfer, business development and corporate finance and develops disruptive unbiased NGS-based diagnostics in the field of infectious diseases